Wyeth on Friday said it is considering cost cuts that could eliminate 10 percent of its work force over a three-year period, although the U.S. drugmak...
A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost profits from sales of Teva Pharmaceutic...